1. Home
  2. SABS vs NWFL Comparison

SABS vs NWFL Comparison

Compare SABS & NWFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SAB Biotherapeutics Inc.

SABS

SAB Biotherapeutics Inc.

HOLD

Current Price

$3.37

Market Cap

288.8M

Sector

Health Care

ML Signal

HOLD

Logo Norwood Financial Corp.

NWFL

Norwood Financial Corp.

HOLD

Current Price

$32.03

Market Cap

346.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SABS
NWFL
Founded
2014
1870
Country
United States
United States
Employees
86
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
288.8M
346.2M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
SABS
NWFL
Price
$3.37
$32.03
Analyst Decision
Strong Buy
Hold
Analyst Count
4
1
Target Price
$10.75
$33.00
AVG Volume (30 Days)
401.9K
13.6K
Earning Date
05-12-2026
04-27-2026
Dividend Yield
N/A
4.39%
EPS Growth
N/A
15150.00
EPS
N/A
0.35
Revenue
N/A
$7,999,000.00
Revenue This Year
N/A
$34.35
Revenue Next Year
N/A
$5.55
P/E Ratio
N/A
$91.17
Revenue Growth
N/A
8.11
52 Week Low
$1.65
$23.70
52 Week High
$6.60
$32.23

Technical Indicators

Market Signals
Indicator
SABS
NWFL
Relative Strength Index (RSI) 41.94 65.24
Support Level $2.84 $28.95
Resistance Level $4.09 N/A
Average True Range (ATR) 0.17 0.71
MACD -0.02 0.22
Stochastic Oscillator 12.50 100.00

Price Performance

Historical Comparison
SABS
NWFL

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders. The company's lead product candidate, SAB-142, targets autoimmune Type 1 Diabetes (T1D) with a disease-modifying therapeutic approach that aims to change the T1D treatment paradigm by delaying onset and potentially preventing disease progression of Stage 3 T1D patients. It is focused on developing product candidates for disease targets where a differentiated approach has the greatest potential to be either first-in-class against novel targets against complex targets to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders.

About NWFL Norwood Financial Corp.

Norwood Financial Corp is a U.S.-based bank holding company. It offers various personal and business credit services, trust and investment products, and real estate settlement services to consumers, businesses, nonprofit organizations, and municipalities in each of the communities that the bank serves. The bank also manages automated teller machines at its branch location. It serves the Pennsylvanian counties of Wayne, Pike, Monroe, and Lackawanna, as well as Susquehanna County.

Share on Social Networks: